269 related articles for article (PubMed ID: 17006874)
1. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
Rockwood K; Black S; Bedard MA; Tran T; Lussier I;
Int J Geriatr Psychiatry; 2007 Apr; 22(4):312-9. PubMed ID: 17006874
[TBL] [Abstract][Full Text] [Related]
2. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease.
Hashimoto M; Yatabe Y; Kaneda K; Honda K; Ikeda M
Psychogeriatrics; 2009 Dec; 9(4):196-203. PubMed ID: 20377821
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease.
Burns A; Gauthier S; Perdomo C
Int J Geriatr Psychiatry; 2007 Aug; 22(8):806-12. PubMed ID: 17199235
[TBL] [Abstract][Full Text] [Related]
4. Verbal repetition in patients with Alzheimer's disease who receive donepezil.
Asp E; Cloutier F; Fay S; Cook C; Robertson ML; Fisk J; Dei DW; Rockwood K
Int J Geriatr Psychiatry; 2006 May; 21(5):426-31. PubMed ID: 16676290
[TBL] [Abstract][Full Text] [Related]
5. A multinational, randomised, 12-week study comparing the effects of donepezil and galantamine in patients with mild to moderate Alzheimer's disease.
Jones RW; Soininen H; Hager K; Aarsland D; Passmore P; Murthy A; Zhang R; Bahra R
Int J Geriatr Psychiatry; 2004 Jan; 19(1):58-67. PubMed ID: 14716700
[TBL] [Abstract][Full Text] [Related]
6. Donepezil treatment of severe Alzheimer's disease in nursing home settings. A responder analysis.
Jelic V; Haglund A; Kowalski J; Langworth S; Winblad B
Dement Geriatr Cogn Disord; 2008; 26(5):458-66. PubMed ID: 18984956
[TBL] [Abstract][Full Text] [Related]
7. Donepezil for cognitive decline following coronary artery bypass surgery: a pilot randomized controlled trial.
Doraiswamy PM; Babyak MA; Hennig T; Trivedi R; White WD; Mathew JP; Newman MF; Blumenthal JA
Psychopharmacol Bull; 2007; 40(2):54-62. PubMed ID: 17514186
[TBL] [Abstract][Full Text] [Related]
8. Long-term safety and efficacy of donepezil in patients with severe Alzheimer's disease: results from a 52-week, open-label, multicenter, extension study in Japan.
Homma A; Imai Y; Tago H; Asada T; Shigeta M; Iwamoto T; Takita M; Arimoto I; Koma H; Takase T; Ohbayashi T
Dement Geriatr Cogn Disord; 2009; 27(3):232-9. PubMed ID: 19246907
[TBL] [Abstract][Full Text] [Related]
9. Cognitive, global, and functional benefits of donepezil in Alzheimer's disease and vascular dementia: results from large-scale clinical trials.
Passmore AP; Bayer AJ; Steinhagen-Thiessen E
J Neurol Sci; 2005 Mar; 229-230():141-6. PubMed ID: 15760632
[TBL] [Abstract][Full Text] [Related]
10. Donepezil in Alzheimer's disease: what to expect after 3 years of treatment in a routine clinical setting.
Wallin AK; Andreasen N; Eriksson S; Båtsman S; Nasman B; Ekdahl A; Kilander L; Grut M; Rydén M; Wallin A; Jonsson M; Olofsson H; Londos E; Wattmo C; Eriksdotter Jonhagen M; Minthon L;
Dement Geriatr Cogn Disord; 2007; 23(3):150-60. PubMed ID: 17312368
[TBL] [Abstract][Full Text] [Related]
11. Donepezil in Alzheimer's disease: a clinical observational study evaluating individual treatment response.
Riepe MW; Kohler J; Horn R
Curr Med Res Opin; 2007 Aug; 23(8):1829-35. PubMed ID: 17599785
[TBL] [Abstract][Full Text] [Related]
12. Prediction of psychiatric response to donepezil in patients with mild to moderate Alzheimer's disease.
Tanaka M; Namiki C; Thuy DH; Yoshida H; Kawasaki K; Hashikawa K; Fukuyama H; Kita T
J Neurol Sci; 2004 Oct; 225(1-2):135-41. PubMed ID: 15465097
[TBL] [Abstract][Full Text] [Related]
13. The relationship between quality of life, Mini-Mental State Examination, and the Instrumental Activities of Daily Living in patients with Alzheimer's disease.
Wlodarczyk JH; Brodaty H; Hawthorne G
Arch Gerontol Geriatr; 2004; 39(1):25-33. PubMed ID: 15158578
[TBL] [Abstract][Full Text] [Related]
14. What happens when donepezil is suddenly withdrawn? An open label trial in dementia with Lewy bodies and Parkinson's disease with dementia.
Minett TS; Thomas A; Wilkinson LM; Daniel SL; Sanders J; Richardson J; Littlewood E; Myint P; Newby J; McKeith IG
Int J Geriatr Psychiatry; 2003 Nov; 18(11):988-93. PubMed ID: 14618549
[TBL] [Abstract][Full Text] [Related]
15. The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial.
Rockwood K; Fay S; Gorman M; Carver D; Graham JE
BMC Neurol; 2007 Aug; 7():26. PubMed ID: 17760991
[TBL] [Abstract][Full Text] [Related]
16. Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey.
Rockwood K; Black SE; Robillard A; Lussier I
Int J Geriatr Psychiatry; 2004 Oct; 19(10):954-60. PubMed ID: 15449367
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of donepezil on maintenance of activities of daily living in patients with moderate to severe Alzheimer's disease and the effect on caregiver burden.
Feldman H; Gauthier S; Hecker J; Vellas B; Emir B; Mastey V; Subbiah P;
J Am Geriatr Soc; 2003 Jun; 51(6):737-44. PubMed ID: 12757558
[TBL] [Abstract][Full Text] [Related]
18. [Impact of music therapy on anxiety and depression for patients with Alzheimer's disease and on the burden felt by the main caregiver (feasibility study)].
Guetin S; Portet F; Picot MC; Defez C; Pose C; Blayac JP; Touchon J
Encephale; 2009 Feb; 35(1):57-65. PubMed ID: 19250995
[TBL] [Abstract][Full Text] [Related]
19. Changes in cognitive functions of patients with dementia of the Alzheimer type following long-term administration of donepezil hydrochloride: relating to changes attributable to differences in apolipoprotein E phenotype.
Kanaya K; Abe S; Sakai M; Fujii H; Iwamoto T
Geriatr Gerontol Int; 2010 Jan; 10(1):25-31. PubMed ID: 20102379
[TBL] [Abstract][Full Text] [Related]
20. Donepezil-induced nightmares in mild cognitive impairment.
Kitabayashi Y; Ueda H; Tsuchida H; Yamashita T; Narumoto J; Fukui K
Psychiatry Clin Neurosci; 2006 Feb; 60(1):123-4. PubMed ID: 16472374
[No Abstract] [Full Text] [Related]
[Next] [New Search]
